Role of SMARCA4 (BRG1) and SMARCB1 (INI1) in Dedifferentiated Endometrial Carcinoma With Paradoxical Aberrant Expression of MMR in the Well-Differentiated Component: A Case Report and Review of the Literature
Authors:
- 17 September 2020
- journal article
- review article
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 29 (5) , 571-577
Abstract
Introduction: Dedifferentiated endometrial carcinoma is an uncommon highly aggressive uterine tumor. It comprises 2 components: a well-differentiated, low-grade epithelial carcinoma and an undifferentiated carcinoma. The undifferentiated carcinoma frequently exhibits rhabdoid cytologic features. Many of these tumors are characterized by an aberrant switch/sucrose non-fermenting (SWI/SNF) complex. They may also exhibit aberrant expression of mismatch repair (MMR) proteins. Together, these play an important role in the pathogenesis and aggressive nature of the tumor. Material and Methods: We present a case of dedifferentiated endometrial carcinoma in a 63-year-old female showing loss of expression of SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 (SMARCA4/BRG1), and aberrant expression of MMR proteins. We also review the literature starting from the earliest recognition of this entity and the various studies done to explain its molecular pathogenesis and prognostic importance. Results and Conclusions: Recognition of SWI/SNF complex-deficient dedifferentiated endometrial carcinoma is important as these tumors do not respond to platinum-based chemotherapy, and consideration of alternative therapies is often necessary. We also want to emphasize that though most of the studies have found MMR deficiency in the undifferentiated carcinoma component, it may be seen only in the low-grade, well-differentiated component, as observed in this case.Keywords
This publication has 13 references indexed in Scilit:
- Clinicopathologic and Immunohistochemical Characterization of Dedifferentiated Endometrioid AdenocarcinomaApplied Immunohistochemistry & Molecular Morphology, 2016
- Immunophenotypic features of dedifferentiated endometrial carcinoma – insights from BRG1/INI1‐deficient tumoursHistopathology, 2016
- Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomasLaboratory Investigation, 2016
- Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma BiomarkersInternational Journal of Gynecological Pathology, 2016
- SWI/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinomaPathology, 2015
- SMARCB1 (INI-1)-deficient Carcinomas of the Sinonasal TractAmerican Journal of Surgical Pathology, 2014
- Dedifferentiation and reprogramming: origins of cancer stem cellsEMBO Reports, 2014
- Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer—Mechanisms and Potential Therapeutic InsightsClinical Cancer Research, 2014
- Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasmsLaboratory Investigation, 2010
- Association of Low-Grade Endometrioid Carcinoma of the Uterus and Ovary With Undifferentiated Carcinoma: A New Type of Dedifferentiated Carcinoma?International Journal of Gynecological Pathology, 2006